Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma

被引:40
|
作者
Cui, Wenli [1 ,2 ,3 ,4 ]
Cai, Ying [1 ,2 ,3 ]
Wang, Weige [1 ,2 ,3 ]
Liu, Zebing [1 ,2 ,3 ]
Wei, Ping [1 ,2 ,3 ]
Bi, Rui [1 ,2 ,3 ]
Chen, Weixiang [1 ,2 ,3 ]
Sun, Menghong [1 ,2 ,3 ]
Zhou, Xiaoyan [1 ,2 ,3 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Pathol, Shanghai 200032, Peoples R China
[4] Xinjiang Med Univ, Affiliated Hosp 1, Dept Pathol, Urumqi 830054, Xinjiang Uygur, Peoples R China
关键词
DLBCL; CNV; PI3K/AKT; Subunits; Survival; INTEGRATIVE GENOMIC ANALYSIS; GENE-EXPRESSION; AKT; PIK3CA; GROWTH; ISOFORMS; ROLES;
D O I
10.1186/1479-5876-12-10
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: It has been reported that the PI3K/AKT signaling pathway is activated in diffuse large B-cell lymphoma (DLBCL), PI3K constitutive activation plays a crucial role in PI3K/AKT pathway. However, the copy number variations (CNVs) of PI3K subunits on gene level remain unknown in DLBCL. Therefore, the aim of the study is to investigate the CNV of PI3K subunits and their relationship with clinicopathological features exploring the possible mechanism underlying of PI3K activation in DLBCL. Methods: CNV of 12 genes in the PI3K/AKT pathway was detected by NanoString nCounter in 60 de novo DLBCLs and 10 reactive hyperplasia specimens as controls. Meanwhile, immunohistochemistry (IHC) was performed to examine the expression of p110 alpha, p110 beta, p110 gamma, p110 delta, and pAKT on DLBCL tissue microarrays. Results: All PI3K and AKT subunits, except for PIK3R1, had various CNVs in the form of copy number amplifications and copy number losses. Their rates were in the range of 8.3-20.0%. Of them PIK3CA and PIK3CB gene CNVs were significantly associated with decreased overall survival (P = 0.029 and P = 0.019, respectively). IHC showed that the frequency of strong positive expression of p110 alpha, p110 beta, p110 gamma, and p110 delta were 26.7%, 25.0%, 18.3%, and 25.0% respectively, and they were found to be associated with decreased survival (P = 0.022, P = 0.015, P = 0.015, and P = 0.008, respectively). Expression of p110 alpha was not only significantly associated with CNVs of PIK3CA (P = 0.002) but also positively correlated with strong positive expression of pAKT (P = 0.026). Conclusions: CNV of PIK3CA is highly associated with aberrant p110a protein expression and subsequent activation of PI3K/AKT pathway. CNVs of PIK3CA and PIK3CB, and aberrant protein expression of p110 isoforms are of great important value for predicting inferior prognosis in DLBCL. Frequent CNVs of PI3K/AKT subunits may play an important role in the tumorigenesis of DLBCL.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Obesity, the PI3K/Akt signal pathway and colon cancer
    Huang, X-F.
    Chen, J-Z.
    OBESITY REVIEWS, 2009, 10 (06) : 610 - 616
  • [42] The PI3K/Akt pathway is not a main driver in HDL-mediated cell protection
    Zheng, Adi
    Dubuis, Gilles
    Ferreira, Carla Susana Mendes
    Petremand, Jannick
    Vanli, Gueliz
    Widmann, Christian
    CELLULAR SIGNALLING, 2019, 62
  • [43] PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
    Zhang, Hai-ping
    Yu, Zi-liang
    Wu, Bing-bing
    Sun, Fa-rui
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [44] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)
  • [45] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [46] Role of the PI3K/AKT pathway and PTEN in otitis media
    Lee, Hwan Ho
    Chin, Anthony
    Pak, Kwang
    Wasserman, Stephen, I
    Kurabi, Arwa
    Ryan, Allen F.
    EXPERIMENTAL CELL RESEARCH, 2020, 387 (01)
  • [47] Investigation of EGFR/pi3k/Akt signaling pathway in seminomas
    Guerra, F.
    Quintana, S.
    Giustina, S.
    Mendeluk, G.
    Jufe, L.
    Avagnina, M. A.
    Diaz, L. B.
    Palaoro, L. A.
    BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (02) : 125 - 137
  • [48] Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
    Markman, Ben
    Dienstmann, Rodrigo
    Tabernero, Josep
    ONCOTARGET, 2010, 1 (07) : 530 - 543
  • [49] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3
  • [50] MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer
    Hu, Mingli
    Zhu, Shixuan
    Xiong, Shengwei
    Xue, Xingxing
    Zhou, Xiaodong
    ONCOLOGY REPORTS, 2019, 41 (03) : 1439 - 1454